OTC Analgesic Label Warnings Should Extend To Advertising, Committee Says
This article was originally published in The Tan Sheet
FDA Nonprescription Drugs Advisory Committee-endorsed labeling changes for OTC analgesics should be reflected in all advertising and educational materials for the products, committee reps suggested
You may also be interested in...
Use of a "black box" warning on OTC acetaminophen labeling would be an inappropriate means for alerting consumers about potential liver damage, two consultants to FDA's Nonprescription Drugs Advisory Committee said Sept. 19
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Perrigo promotes in pricing, planning